GM Advisory Group LLC Buys 160 Shares of Marsh & McLennan Companies, Inc. (NYSE:MMC)

GM Advisory Group LLC raised its stake in Marsh & McLennan Companies, Inc. (NYSE:MMC) by 4.0% in the 3rd quarter, HoldingsChannel reports. The firm owned 4,196 shares of the financial services provider’s stock after acquiring an additional 160 shares during the quarter. GM Advisory Group LLC’s holdings in Marsh & McLennan Companies were worth $936,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Fortitude Family Office LLC grew its position in shares of Marsh & McLennan Companies by 18.8% in the third quarter. Fortitude Family Office LLC now owns 285 shares of the financial services provider’s stock valued at $64,000 after purchasing an additional 45 shares in the last quarter. Kingfisher Capital LLC grew its holdings in Marsh & McLennan Companies by 4.7% during the 2nd quarter. Kingfisher Capital LLC now owns 1,042 shares of the financial services provider’s stock valued at $220,000 after buying an additional 47 shares in the last quarter. Drive Wealth Management LLC increased its position in shares of Marsh & McLennan Companies by 3.7% during the second quarter. Drive Wealth Management LLC now owns 1,382 shares of the financial services provider’s stock valued at $291,000 after buying an additional 49 shares during the period. Legacy Financial Advisors Inc. boosted its position in shares of Marsh & McLennan Companies by 2.3% in the second quarter. Legacy Financial Advisors Inc. now owns 2,222 shares of the financial services provider’s stock valued at $468,000 after acquiring an additional 49 shares during the period. Finally, Ritholtz Wealth Management grew its stake in Marsh & McLennan Companies by 0.6% during the second quarter. Ritholtz Wealth Management now owns 8,953 shares of the financial services provider’s stock valued at $1,887,000 after acquiring an additional 51 shares in the last quarter. Institutional investors own 87.99% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages have commented on MMC. Roth Mkm raised their price target on shares of Marsh & McLennan Companies from $220.00 to $230.00 and gave the company a “neutral” rating in a report on Friday, October 18th. The Goldman Sachs Group set a $220.00 price objective on Marsh & McLennan Companies and gave the company a “sell” rating in a research note on Friday, October 18th. Barclays upped their target price on Marsh & McLennan Companies from $236.00 to $246.00 and gave the stock an “equal weight” rating in a research note on Thursday. BMO Capital Markets upped their price objective on shares of Marsh & McLennan Companies from $217.00 to $228.00 and gave the stock a “market perform” rating in a research report on Tuesday, October 22nd. Finally, UBS Group boosted their target price on Marsh & McLennan Companies from $255.00 to $259.00 and gave the stock a “buy” rating in a research report on Tuesday, October 22nd. Two investment analysts have rated the stock with a sell rating, twelve have issued a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of $226.00.

Insider Buying and Selling at Marsh & McLennan Companies

In other news, Director Oscar Fanjul sold 2,500 shares of the firm’s stock in a transaction dated Wednesday, October 30th. The shares were sold at an average price of $221.55, for a total value of $553,875.00. Following the sale, the director now directly owns 48,549 shares in the company, valued at approximately $10,756,030.95. This trade represents a 4.90 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 0.30% of the company’s stock.

Marsh & McLennan Companies Trading Up 1.3 %

Shares of NYSE MMC opened at $224.93 on Friday. The company has a debt-to-equity ratio of 0.89, a current ratio of 1.14 and a quick ratio of 1.14. The business’s 50 day moving average is $223.70 and its two-hundred day moving average is $218.54. Marsh & McLennan Companies, Inc. has a 1-year low of $184.28 and a 1-year high of $232.32. The stock has a market capitalization of $110.47 billion, a P/E ratio of 27.70, a PEG ratio of 3.29 and a beta of 0.94.

Marsh & McLennan Companies (NYSE:MMC) last released its quarterly earnings data on Thursday, October 17th. The financial services provider reported $1.63 earnings per share for the quarter, beating the consensus estimate of $1.61 by $0.02. Marsh & McLennan Companies had a return on equity of 32.65% and a net margin of 16.82%. The firm had revenue of $5.70 billion during the quarter, compared to the consensus estimate of $5.71 billion. During the same period in the previous year, the company posted $1.57 earnings per share. The firm’s quarterly revenue was up 5.9% on a year-over-year basis. As a group, research analysts expect that Marsh & McLennan Companies, Inc. will post 8.69 EPS for the current year.

Marsh & McLennan Companies Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, November 15th. Investors of record on Friday, October 4th were paid a $0.815 dividend. This represents a $3.26 dividend on an annualized basis and a yield of 1.45%. The ex-dividend date of this dividend was Friday, October 4th. Marsh & McLennan Companies’s dividend payout ratio (DPR) is 40.15%.

Marsh & McLennan Companies Profile

Marsh & McLennan Companies, Inc, a professional services company, provides advice and solutions to clients in the areas of risk, strategy, and people worldwide. It operates through Risk and Insurance Services, and Consulting segments. The Risk and Insurance Services segment offers risk management services, such as risk advice, risk transfer, and risk control and mitigation solutions, as well as insurance and reinsurance broking, strategic advisory services, and analytics solutions, and insurance program management services.